SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis.

Area of Science:

• Hepatology
• Cell Biology
• Biomedical Engineering

Background:

• Liver fibrosis, a response to chronic liver injury, involves extracellular matrix accumulation and scar tissue formation.
• Current treatments for liver fibrosis lack FDA approval, highlighting an unmet medical need.
• Liver sinusoidal endothelial cells (LSECs) are critical nonparenchymal cells supporting liver function.

Purpose of the Study:

• To review the interplay between LSECs and the dynamic fibrotic liver microenvironment.
• To provide insights into pivotal changes in LSEC physiology during liver fibrosis.
• To explore the role of LSECs in mediating liver fibrosis progression.

Main Methods:

• Literature review focusing on LSEC alterations in fibrotic liver disease.
• Analysis of studies examining microenvironmental factors (matrix rigidity, ECM profile, cell-cell interactions) affecting LSECs.
• Synthesis of current knowledge on LSEC phenotype changes and their functional consequences.

Main Results:

• Alterations in LSEC phenotype, including loss of fenestration and capillarization, precede fibrosis and activate hepatic stellate cells.
• The fibrotic microenvironment, characterized by increased matrix rigidity and altered ECM, significantly impacts LSEC physiology.
• LSECs are pivotal in mediating the progression of liver fibrosis through their interactions within the changing tissue milieu.

Conclusions:

• Understanding the molecular mechanisms of LSECs in the fibrotic microenvironment is essential for developing novel therapeutic and diagnostic strategies for liver fibrosis.
• Targeting LSEC dysfunction presents a promising avenue for future liver fibrosis interventions.
• Further research into LSEC-microenvironment interactions can accelerate the development of effective treatments for liver fibrosis.